From Pipeline to Commercialization - with Stan Miele
- Stan's career and experience: Stan shares his career journey from his previous roles to his current position in AQUALUNG THERAPEUTICS CORP. He's leading the commercialization process.
- Journey to commercialization: Stan discusses the ongoing development of AQUALUNG THERAPEUTICS CORP., an early-stage biotech company focused on addressing runaway or unchecked inflammation and fibrosis.
- Challenges faced by startups: Stan highlights the evolving challenges for startups in the health sector, with capital raising being a prominent issue. He notes the shift from "hype" to substance in funding, emphasizing the need for substantiated and validated scientific research.
- Clinical development: Stan shares the unique challenges that AQUALUNG THERAPEUTICS CORP. faces in clinical development, discussing the importance of personalized or predictive medicine approaches.
- Interactions with the FDA: Stan outlines Aqua Therapeutics' interactions with the FDA and talks about the role of biomarkers and companion diagnostics in their drug development.
- Impact of the Covid-19 pandemic: Stan recounts how the pandemic accelerated their timelines and process, given the relevance of their research in addressing acute respiratory distress syndrome, a condition related to severe Covid-19.
Listen to the full episode for deeper insights into the complexities and exciting potential of the health sector, as shared by Stan Mealy.
Creators and Guests
Host
Rick Gannotta
Health sector executive clinician educator & researcher, RTs/links 🚫 not endorsements, TEDX; https://t.co/51mnBxpPqv @NYUWagner